Better patient information would improve consent process for anaesthetic drugs

Davis and colleagues highlight the critical need for clearer and more accessible information about medicines for patients.1 As an anaesthetist, I often encounter challenges in communicating the risks and benefits of perioperative drugs, particularly as we cannot always predict every medication that might be required during an operation.

A key example is sugammadex, a neuromuscular …